Not provided
Not provided
Not provided
Not provided
Not provided
Difficulties in patient recruitment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the study is to evaluate whether a computer-based cognitive treatment delivered via tele-rehabilitation produces an improvement in cognitive functioning comparable to the improvement achievable through the same treatment delivered in person in patients with stroke outcomes.
To investigate, using a custom-designed questionnaire, the feasibility and patient satisfaction with the rehabilitative treatment delivered via telemedicine compared to the same treatment delivered in person.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Telerehabilitation group | Experimental | Three hours of cognitive rehabilitation per week, performed remotely and independently, using a computerized device, which is pre-programmed based on the patient's needs. |
|
| In-person treatment | Active Comparator | Three hours of in-person cognitive rehabilitation per week using a computerized device. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Telerehabilitation | Behavioral | Three hours of cognitive rehabilitation per week, performed remotely and independently, using a computerized device, which is pre-programmed based on the patient's needs. |
| Measure | Description | Time Frame |
|---|---|---|
| Trail Making Test Part B (TMT-B) | Used as a measure of attentional set-shifting and mental flexibility. Time needed to complete the tasks is recorded. | From enrollment to the end of treatment and 2 months until the end of treatment |
| Measure | Description | Time Frame |
|---|---|---|
| The Trail Making Test - A (TMT-A) | Used as a measure of psychomotor speed and visual search/attention skills | From enrollment to the end of treatment and 2 months until the end of treatment |
| 15 Words of Rey |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sezione medicina fisica e riabilitativa dipartimento di neuroscienze | Verona | verona | Italy |
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069350 | Telerehabilitation |
| ID | Term |
|---|---|
| D012046 | Rehabilitation |
| D000359 | Aftercare |
| D003266 | Continuity of Patient Care |
| D005791 | Patient Care |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Traditional in-person rehabilitation. | Behavioral | Three hours of in-person cognitive rehabilitation per week using a computerized device. |
|
To assess verbal learning ability and long-term verbal memory (IMMEDIATE RECALL: score ranging from 0 to 75. DELAYED RECALL: score ranging from 0 to 15).
| From enrollment to the end of treatment and 2 months until the end of treatment |
| Memory with interference - ENB 2 | to assess working memory through the memorization of letter triplets alongside a distracting task lasting 10 seconds in the first part and 30 seconds in the second. The maximum obtainable score is 9 for both parts of the test. | From enrollment to the end of treatment and 2 months until the end of treatment |
| Dual task test | Dual Task to assess the ability to perform two tasks simultaneously (one verbal and one visuomotor) | From enrollment to the end of treatment and 2 months until the end of treatment |
| Elithorn's Perceptual Maze Test | to investigate problem-solving abilities. | From enrollment to the end of treatment and 2 months until the end of treatment |
| Stroop Test | to assess the speed and accuracy of automatic response inhibition. | From enrollment to the end of treatment and 2 months until the end of treatment |
| Functional Independence Measure (FIM) | To evaluate the degree of disability. | From enrollment to the end of treatment and 2 months until the end of treatment |
| Hospital Anxiety and Depression Scale | to assess the presence of depression and anxiety. | From enrollment to the end of treatment and 2 months until the end of treatment |
| Short Form Health Survey 36 (SF-36) | to evaluate quality of life. | From enrollment to the end of treatment and 2 months until the end of treatment |
| Feasibility, Satisfaction, and Cost Questionnaire | to assess the feasibility and satisfaction with the treatment and to evaluate the costs associated with it. | From enrollment to the end of treatment and 2 months until the end of treatment |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D013812 |
| Therapeutics |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
| D017216 | Telemedicine |
| D003695 | Delivery of Health Care |
| D010346 | Patient Care Management |
| D006298 | Health Services Administration |